NEW YORK (GenomeWeb) – Molecular diagnostics maker Hibergene has closed a Series B funding round of €6.7 million ($7.2 million), the company announced today. The new funds will expand the firm's research and development programs and its international distributor network.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.